A prospective, randomized comparative study of monopolar transurethral resection of the prostate versus photoselective vaporization of the prostate with GreenLight 120-W laser, in prostates less than 80 cc
- PMID: 25642290
- PMCID: PMC4294803
- DOI: 10.1177/1756287214556643
A prospective, randomized comparative study of monopolar transurethral resection of the prostate versus photoselective vaporization of the prostate with GreenLight 120-W laser, in prostates less than 80 cc
Abstract
Objective: In this study we aimed to compare photoselective vaporization (PVP) with the GreenLight 120-W Laser and monopolar transurethral resection as surgical treatments of prostates less than 80 cc in men with obstructive benign prostatic hyperplasia.
Methods: From February 2009 to March 2012 we allocated 101 patients with a prostate glands of less than 80 cc; patients were randomly assigned for surgical treatment with monopolar transurethral resection of the prostate (TURP) (n = 62) or PVP (n = 39). Serum prostate specific antigen (PSA), International Prostate Symptom Score (IPSS), Sexual Health Inventory for Men (SHIM), maximum flow rate (Qmax) postmicturition residual (PMR), transrectal ultrasound volumes (TRUS), postvoid urine residual (PVR), complications, re-operations and hospitalization time were collected. The patients were seen in the follow up at 6, 12 and 24 months.
Results: Median age was 69 (56-87) years old in the TURP group and 67 (51-87) years old in the PVP group. Mean preoperative prostate volume was 55 cc (40-72) and 60 cc (41-75) cc in the TURP group versus the PVP group. There was no statistically difference in subjectively (IPSS, SHIM) and objectively (Qmax-PMR) parameters and postoperatively complication rates between the two groups (p > 0.05). A significant difference was observed in the PVP group with a 2 (1-4) days hospital stay compared with 5 (3-9) days for the TURP group (p < 0.001).
Conclusion: Prostate PVP and TURP are effective surgical treatments for benign prostatic hyperplasia. Postoperative functional improvements were durable and equivalent in the two groups. The two techniques have a similar complication rate.
Keywords: GreenLight; photoselective vaporization of prostate; prostatectomy; prostatic hyperplasia; transurethral resection of prostate.
Conflict of interest statement
Similar articles
-
Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.J Urol. 2014 Jan;191(1):148-54. doi: 10.1016/j.juro.2013.06.113. Epub 2013 Jul 8. J Urol. 2014. PMID: 23845460
-
980-Nm Diode Laser Vaporization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: Randomized Controlled Study.Urol J. 2015 Nov 14;12(5):2355-61. Urol J. 2015. PMID: 26571321 Clinical Trial.
-
Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial.Urology. 2008 Feb;71(2):247-51. doi: 10.1016/j.urology.2007.09.017. Urology. 2008. PMID: 18308094 Clinical Trial.
-
GreenLight Laser™ Photovaporization versus Transurethral Resection of the Prostate: A Systematic Review and Meta-Analysis.Res Rep Urol. 2021 May 20;13:263-271. doi: 10.2147/RRU.S277482. eCollection 2021. Res Rep Urol. 2021. PMID: 34295844 Free PMC article. Review.
-
[Safety and effectiveness of GreenLight 120-W laser photoselective vaporization of the prostate for benign prostatic hyperplasia: A meta-analysis].Zhonghua Nan Ke Xue. 2015 Jul;21(7):646-54. Zhonghua Nan Ke Xue. 2015. PMID: 26333229 Review. Chinese.
Cited by
-
Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis.Sci Rep. 2016 Mar 24;6:23503. doi: 10.1038/srep23503. Sci Rep. 2016. PMID: 27009501 Free PMC article.
-
A systematic review and meta-analysis of efficacy and safety comparing greenlight laser vaporization with transurethral resection of the prostate for benign prostatic hyperplasia with prostate volume less than 80 ml.Lasers Med Sci. 2023 Jun 8;38(1):133. doi: 10.1007/s10103-023-03794-2. Lasers Med Sci. 2023. PMID: 37289405
-
A Systematic Review and Meta-Analysis of Functional Outcomes and Complications Following the Photoselective Vaporization of the Prostate and Monopolar Transurethral Resection of the Prostate.World J Mens Health. 2016 Aug;34(2):110-22. doi: 10.5534/wjmh.2016.34.2.110. Epub 2016 Aug 23. World J Mens Health. 2016. PMID: 27574594 Free PMC article.
-
Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.Transl Androl Urol. 2019 Oct;8(5):529-539. doi: 10.21037/tau.2019.10.01. Transl Androl Urol. 2019. PMID: 31807429 Free PMC article. Review.
-
Urethral stricture following endoscopic prostate surgery: a systematic review and meta-analysis of prospective, randomized trials.World J Urol. 2022 Jun;40(6):1391-1411. doi: 10.1007/s00345-022-03946-z. Epub 2022 Feb 13. World J Urol. 2022. PMID: 35152322
References
-
- Al-Ansari A., Younes N., Sampige V., Al-Rumaihi K., Ghafouri A., Gul T., et al. (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58: 349–355. - PubMed
-
- Bachmann A., Ruszat R., Wyler S., Reich O., Seifert H., Müller A., et al. (2005a) Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 47: 798–804. - PubMed
-
- Bachmann A., Schürch L., Ruszat R., Wyler S., Seifert H., Müller A., et al. (2005b) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48: 965–971; discussion 972. - PubMed
-
- Bachmann A., Tubaro A., Barber N., d’Ancona F., Muir G., Witzsch U., et al. (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European multicentre randomised trial – the GOLIATH study. Eur Urol 65: 931–942. - PubMed
-
- Barry M., Williford W., Chang Y., Machi M., Jones K., Walker-Corkery E., et al. (1995) Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients? J Urol 154: 1770–1774. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous